Point72 Asset Management
AMAG

Point72 Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Point72 Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-29,500
Closed -$590K – 1318
2018
Q3 		$590K Buy
+29,500
New +$672K ﹤0.01% 914
2016
Q3 		– Sell
-446,300
Closed -$10.7M – 907
2016
Q2 		$10.7M Buy
+446,300
New +$10.2M 0.07% 287

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management's AMAG Position: Q4 2018 in Review

Point72 Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2018, closing a stake of 29,500 shares — an estimated $590K sold.

Point72 Asset Management first reported a position in AMAG in Q2 2016 and held it in 2 quarters. The position peaked at $10.7M in Q2 2016. 190 funds tracked by Wall St. Rank hold AMAG as of Q4 2018.

  • Point72 Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Point72 Asset Management sold 29,500 AMAG Pharmaceuticals shares in Q4 2018, an estimated $590K.
  • Point72 Asset Management first reported a position in AMAG Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Point72 Asset Management's AMAG Pharmaceuticals position peaked at $10.7M in Q2 2016.
  • 190 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2018.

Based on Point72 Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.